ICTRP enhances transparency by requiring that all clinical trials be registered before they begin, with their details made publicly accessible. This includes trial objectives, methodologies, participant eligibility criteria, and outcomes. For cancer trials, this transparency is crucial as it helps patients and healthcare providers make informed decisions about participation in trials and understand the potential risks and benefits of new treatments.
